World-Leading Gene Editing Technology Unveiled in United Kingdom

Dublin, Oct. 23, 2023 (GLOBE NEWSWIRE) -- In a momentous stride toward the future of agriculture, scientists have recently achieved a remarkable breakthrough in the realm of gene editing. The creation of the world's first flu-resistant chickens, signals a turning point in biotechnology, offering promising prospects for gene-edited poultry in the United Kingdom. The addition of the new "United Kingdom Gene Editing Technology Business and Investment Opportunities Databook" added to's offering, explores the wider gene editing technology market.

A recently published study, featured in a Nature Communications article, showcases how minor alterations to a single gene rendered these chickens highly resistant to avian flu. An astounding nine out of ten birds displayed no signs of infection when exposed to a typical dose of the virus. While complete immunity remains a goal, this achievement underscores the potential of gene editing in poultry farming.

Professor Wendy Barclay of Imperial College London, a co-author of the study, explained, "Under natural doses, our gene-edited chickens truly appeared resistant. However, when subjected to an exceptionally high dose, we observed breakthrough infections in half of the chickens. This demonstrates that we are moving closer to creating virus-resistant chickens, though there is work to be done."

These developments are not isolated but part of a broader narrative of growth in the United Kingdom's gene editing technology market. According to the newly released "UK Gene Editing Technology Databook", the market is projected to witness a staggering CAGR of 21.2% from 2023 to 2027, reaching an estimated value of US$0.459 billion by 2027, up from US$0.175 billion in 2023. Over the past five years, the sector has experienced a remarkable CAGR of 27.1%, culminating in a value of US$0.138 billion in 2022.

The databook offers a data-centric analysis of the burgeoning gene editing industry in the UK. It provides a comprehensive overview of market size and forecasts across various segments, including gene editing technologies such as CRISPR, meganucleases, TALEN, and ZFN, as well as by products, delivery methods, disease/disorders, and applications.

Key segments covered in the databook include:

  • Technology: CRISPR CAS 9, TALENs, ZFN, and Others (Meganucleases)
  • CRISPR Products: Kits & Enzymes, Cell Lines & Antibodies, and Others (Plasmid, Controls)
  • TALENs Products: Kits & Enzymes, Cell Lines & Antibodies, and Others (Plasmid, Controls)
  • ZFNs Products: Kits & Enzymes, Cell Lines & Antibodies, and Others (Plasmid, Controls)
  • Meganucleases Products: Kits & Enzymes, Cell Lines & Antibodies, and Others (Plasmid, Controls)
  • Delivery Method: Ex-vivo and In-vivo
  • Disease/Disorders: Cancer, Blood Disorders (beta-thalassemia and sickle cell disease), Blindness, Respiratory Disease (COVID-19 & Cystic fibrosis), and Others (AIDS, Huntington’s disease, Muscular dystrophy)
  • Application: Drug Development, Diagnostics, Plant Gene Editing, and Others (Animal Gene Editing)
  • End-User: Pharmaceutical and Biopharmaceutical Companies, Biotechnology Companies, Contract Research Organisations, and Academic Institutes and Research Centres

The databook equips entrepreneurs, business managers, and investors with an in-depth understanding of the dynamic gene editing market in the United Kingdom. It empowers them to identify growth segments, formulate tailored investment strategies, and assess key trends, drivers, and risks within the industry.

In a world where innovation is the driving force behind business success, the "United Kingdom Gene Editing Technology Business and Investment Opportunities Databook - Q2 2023 Update" serves as an indispensable resource for those seeking to capitalize on the burgeoning gene editing technology sector. It provides invaluable insights, enabling stakeholders to stay ahead in the rapidly evolving landscape of biotechnology.

For more information and to secure your copy of this transformative databook, please visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.